Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview

by Roudi, Raheleh, Syn, Nicholas L., Roudbary, Maryam
Published in Front Immunol (2017)

MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells

by Korourian, Alireza, Roudi, Raheleh, Shariftabrizi, Ahmad, Madjd, Zahra
Published in Exp Biol Med (Maywood) (2017)

DNA Microarray for Rapid Detection and Identification of Food and Water Borne Bacteria: From Dry to Wet Lab

by Ranjbar, Reza, Behzadi, Payam, Najafi, Ali, Roudi, Raheleh
Published in Open Microbiol J (2017)

Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients

by Fathi, Zahra, Mousavi, Seyed Ali Javad, Roudi, Raheleh, Ghazi, Farideh
Published in PLoS One (2018)

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549

by Roudi, Raheleh, Madjd, Zahra, Ebrahimi, Marzieh, Samani, Fazel Sahraneshin, Samadikuchaksaraei, Ali
Published in Cell Mol Biol Lett (2013)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

by Roviello, Giandomenico, D'Angelo, Alberto, Roudi, Raheleh, Petrioli, Roberto, Mini, Enrico
Published in J Oncol (2019)

Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer

by Vafaei, Somayeh, Roudi, Raheleh, Madjd, Zahra, Aref, Amir Reza, Ebrahimi, Marzieh
Published in Cancer Cell Int (2020)

Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol

by Rasti, Arezoo, Mehrazma, Mitra, Madjd, Zahra, Keshtkar, Abbas Ali, Roudi, Raheleh, Babashah, Sadegh
Published in BMJ Open (2016)

Association of homeobox B13 (HOXB13) gene variants with prostate cancer risk in an Iranian population

by Roudi, Raheleh, Nemati, Hosein, Rastegar Moghadam, Mahsa, Sotoudeh, Mehdi, Narouie, Behzad, Shojaei, Azadeh
Published in Med J Islam Repub Iran (2018)

Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients

by Roudi, Raheleh, Barodabi, Mahboubeh, Madjd, Zahra, Roviello, Giandomenico, Corona, Silvia Paola, Panahi, Mahshid
Published in Mol Cell Oncol (2020)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma

by Zhou, Jian-Guo, Zhong, Hua, Zhang, Juan, Jin, Su-Han, Roudi, Raheleh, Ma, Hu
Published in Front Oncol (2019)

Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent

by Zhu, Jianwei, Li, Rui, Tiselius, Eva, Roudi, Raheleh, Teghararian, Olivia, Suo, Chen, Song, Huan
Published in Cochrane Database Syst Rev (2017)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

by Sobhani, Navid, Tardiel-Cyril, Dana Rae, Davtyan, Aram, Generali, Daniele, Roudi, Raheleh, Li, Yong
Published in Cancers (Basel) (2021)

Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis

by Sun, Xiaoying, Roudi, Raheleh, Chen, Shangya, Fan, Bin, Li, Hong Jin, Zhou, Min, Li, Xin, Li, Bin
Published in Medicine (Baltimore) (2017)

Resisting resistance to cancer immunotherapy

by Lam, Walter Sze‐Tung, Wang, Louis Zizhao, Roudi, Raheleh, Yong, Wei‐Peng, Syn, Nicholas L., Sundar, Raghav
Published in Thorac Cancer (2018)

Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol

by Li, Feng, Liu, Guangyu, Roudi, Raheleh, Huang, Qi, Swierzy, Marc, Ismail, Mahmoud, Zhao, Song, Rueckert, Jens-Carsten
Published in BMJ Open (2018)

Co‐expression of TLR‐9 and MMP‐13 is associated with the degree of tumour differentiation in prostate cancer

by Kalantari, Elham, Abolhasani, Maryam, Roudi, Raheleh, Farajollahi, Mohammad M., Farhad, Seif, Madjd, Zahra, Askarian‐Amiri, Shaghayegh, Mohsenzadegan, Monireh
Published in Int J Exp Pathol (2019)

Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics

by Saeednejad Zanjani, Leili, Madjd, Zahra, Rasti, Arezoo, Asgari, Mojgan, Abolhasani, Maryam, Tam, Kevin J., Roudi, Raheleh, Mælandsmo, Gunhild Mari, Fodstad, Øystein, Andersson, Yvonne
Published in Front Oncol (2019)

Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first‐line treatment of advanced non‐small cell lung cancer: a generic protocol

by Syn, Nicholas LX, Roudi, Raheleh, Wang, Louis Zizhao, Wang, Lingzhi, Loh, Marie, Huang, Yiqing, Ou, Sai‐Hong Ignatius, Soong, Richie, Drilon, Alexander, Wee, Ian
Published in Cochrane Database Syst Rev (2018)

Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic revi...

by Sun, Xiaoying, Roudi, Raheleh, Dai, Ting, Chen, Shangya, Fan, Bin, Li, Hongjin, Zhou, Yaqiong, Zhou, Min, Zhu, Bo, Yin, Chengqian, Li, Bin, Li, Xin
Published in BMC Cancer (2019)